Tag: NOBLE

CABG shows 10-year benefit over PCI in left main patients with...

Extended 10-year follow-up has demonstrated that in patients with a high SYNTAX score undergoing left main coronary artery (LMCA) revascularisation there is a clear...
Corresponding author Evald Hoj Christiansen

NOBLE finds PCI inferior to CABG at five years in left...

Five-year data from the NOBLE trial have confirmed its earlier findings that in patients with unprotected left main coronary disease the risk of major...

TCT 2016: Different endpoints may have led to different outcomes for...

Two randomised controlled trials have produced what appears to be conflicting results for how left main percutaneous coronary intervention (PCI) compares with coronary artery...